You have 9 free searches left this month | for more free features.

T/NK-cell

Showing 9976 - 10000 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hematopoietic Stem Cell Transplant Trial in Cincinnati (12-16 hour nutrition)

Active, not recruiting
  • Hematopoietic Stem Cell Transplant
  • 12-16 hour nutrition
  • Cincinnati, Ohio
    Cincinnati Children's Hospital
Oct 14, 2022

Plasmodium Falciparum Trial run by the (NMRC-M3V-Ad-PfCA, NMRC-MV-Ad-PfC, NMRC-M3V-Ad-PfCA)

Completed
  • Plasmodium Falciparum
  • NMRC-M3V-Ad-PfCA
  • NMRC-MV-Ad-PfC, NMRC-M3V-Ad-PfCA
  • Bethesda, Maryland
    Naval Medical Research Center (NMRC) Clinical Trials Center
Apr 28, 2021

NSCLC NSCLC Trial in Worldwide (Durvalumab, Placebo for Olaparib, Olaparib)

Active, not recruiting
  • Non-small Cell Lung Cancer NSCLC
  • Bonita Springs, Florida
  • +67 more
Nov 15, 2022

Diffuse Large B Cell Lymphoma Trial in Shanghai (zanubrutinib)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Mar 13, 2022

Infertility, Female, of Uterine Origin, Endometrial Fibrosis Trial in Nanjing (CBD-bFGF, Collagen/BMMNCs, Estrogen)

Recruiting
  • Infertility, Female, of Uterine Origin
  • Endometrial Fibrosis
  • Nanjing, Jiangsu, China
    Nanjing Drum Tower Hospital
Sep 27, 2022

Refractory Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia Trial in

Completed
  • Refractory Chronic Lymphocytic Leukemia
  • +4 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Mar 15, 2021

Metastatic Renal Cell Carcinoma Trial in Milan (Cabometyx)

Completed
  • Metastatic Renal Cell Carcinoma
  • Milan, Italy
    Fondazione IRCCS Istituto Nazionale Tumori
Apr 23, 2021

Gastric Cancer, NSCLC, Colo-rectal Cancer Trial in Changchun (Ramucirumab Injection, Ramucirumab Injection [Cyramza])

Completed
  • Gastric Cancer
  • +2 more
  • Ramucirumab Injection
  • Ramucirumab Injection [Cyramza]
  • Changchun, Jilin, China
    Affiliated Hospital of Changchun University of Traditional Chine
Mar 24, 2023

Lymphoma, Non-Hodgkin, Chronic Lymphocytic Leukemia Trial in Worldwide (JNJ-64264681, JNJ-67856633)

Active, not recruiting
  • Lymphoma, Non-Hodgkin
  • Chronic Lymphocytic Leukemia
  • Stony Brook, New York
  • +27 more
Aug 11, 2022

Metastatic Colorectal Cancer, Metastatic Pancreatic Cancer, Metastatic Ovarian Cancer Trial run by the National Cancer Institute

Recruiting
  • Metastatic Colorectal Cancer
  • +4 more
  • Young TIL
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 25, 2023

Stroke Trial (Chin tuck against resistance exercise)

Not yet recruiting
  • Stroke
  • Chin tuck against resistance exercise
  • (no location specified)
Aug 25, 2023

NSCLC Trial in NanCHang (V9, )

Recruiting
  • Non-small Cell Lung Cancer
  • V9
  • placebo
  • NanCHang, Jiang XI, China
    Chunling Jiang
Oct 17, 2021

Histiocytosis Trial in Beijing (68Ga-FAPI)

Not yet recruiting
  • Histiocytosis
  • 68Ga-FAPI
  • Beijing, China
    Department of Nuclear Medicine, Peking Union Medical College Hop
Mar 25, 2023

Specific Protein Overexpression in Adult Non-Small Cell Lung

Not yet recruiting
  • Non Small Cell Lung Cancer
    • (no location specified)
    Sep 29, 2023

    Thromboembolism of Vein VTE in Colorectal Cancer, Thromboembolism of Vein in Pancreatic Cancer, Thromboembolism of Vein in NSCLC

    Completed
    • Thromboembolism of Vein VTE in Colorectal Cancer
    • +2 more
    • Los Angeles, California
    • +10 more
    Feb 11, 2021

    Squamous Cell Carcinoma of Head and Neck Trial in Italy (Nivolumab 240 MG in 24 ML Injection)

    Completed
    • Squamous Cell Carcinoma of Head and Neck
    • Nivolumab 240 MG in 24 ML Injection
    • Bergamo, Italy
    • +22 more
    Apr 4, 2023

    Myasthenia Gravis, Generalized Myasthenia, AChR Myasthenia Gravis Trial in Chicago (CNP-106, Placebo)

    Not yet recruiting
    • Myasthenia Gravis
    • +3 more
    • Chicago, Illinois
      Research Site
    Oct 30, 2023

    NSCLC Trial in Melbourne, London (Pembrolizumab, Radiotherapy (SABR))

    Completed
    • Non-small Cell Lung Cancer
    • Melbourne, Victoria, Australia
    • +1 more
    May 23, 2022

    Lymphoma, B-Cell, Chronic Lymphocytic Leukemia Trial in United States (FT596, Cyclophosphamide, Fludarabine)

    Recruiting
    • Lymphoma, B-Cell
    • Chronic Lymphocytic Leukemia
    • Chicago, Illinois
    • +8 more
    Jun 21, 2022

    Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Rochester (Bortezomib, Metformin Hydrochloride,

    Active, not recruiting
    • Recurrent Plasma Cell Myeloma
    • Refractory Plasma Cell Myeloma
    • Jacksonville, Florida
    • +1 more
    Jan 5, 2023

    Retinitis Pigmentosa, Stem Cell Transplant Trial in Istanbul (Stem cell implantation)

    Completed
    • Retinitis Pigmentosa
    • Stem Cell Transplant
    • Stem cell implantation
    • Istanbul, Turkey
      Acıbadem University
    Jan 25, 2023

    Interstitial Lung Disease, Surfactant Dysfunction Trial in Shanghai (Hydroxychloroquine)

    Not yet recruiting
    • Interstitial Lung Disease
    • Surfactant Dysfunction
    • Shanghai, Shanghai, China
      Children's hospital of Fudan University
    Jan 9, 2023

    Sickle Cell Disease Trial in Chicago (drug, radiation, procedure)

    Recruiting
    • Sickle Cell Disease
    • Chicago, Illinois
      University of Illinois at Chicago
    Oct 21, 2021

    Sickle Cell Disease, Sickle Cell Trait Trial in Gainesville (CHOICES, eBook)

    Recruiting
    • Sickle Cell Disease
    • Sickle Cell Trait
    • CHOICES
    • eBook
    • Gainesville, Florida
      University of Florida
    May 31, 2022

    Metastatic Lung Cancer Trial in Villejuif (DS-1062a)

    Recruiting
    • Metastatic Lung Cancer
    • Villejuif, France
      Gustave Roussy
    Jun 17, 2021